Evidence map›Paper›PMID 31114200›Full record

ArticleInternational journal of nanomedicine2019

Antioxidant and toxicity studies of biosynthesized cerium oxide nanoparticles in rats.

Mohammad Bagher Khorrami, Hamid Reza Sadeghnia, Alireza Pasdar, Majid Ghayour-Mobarhan, Bamdad Riahi-Zanjani, Alireza Hashemzadeh, Mohammad Zare, Majid Darroudi

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Food science & nutrition · 2024
    Article
  5. Article
  6. Article
  7. Injection of Cerium Oxide Nanoparticles to Treat Spinal Cord Injury in Rats.Journal of neuropathology and experimental neurology · 2022
    Article
  8. Foliar Application of Cerium Oxide-Salicylic Acid Nanoparticles (CeOInternational journal of molecular sciences · 2022
    Article
  9. Article
  10. Review
  11. Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye.International journal of molecular sciences · 2021
    Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Recent progress of nanomedicine in managing dry eye disease.Advances in ophthalmology practice and research
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Mohammad Bagher KhorramiDepartment of Modern Sciences and Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Hamid Reza SadeghniaDivision of Neurocognitive Sciences, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran, sadeghniahr@mums.ac.ir.
Alireza PasdarDepartment of Modern Sciences and Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Majid Ghayour-MobarhanBiochemistry of Nutrition Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Bamdad Riahi-ZanjaniMedical Toxicology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Alireza HashemzadehNanoBioEletrochemistry Research Center, Bam University of Medical Sciences, Bam, Iran.
Mohammad ZareSocial Security Organization, 17th Shahrivar Hospital, Mashhad, Iran.
Majid DarroudiNuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran, darroudim@mums.ac.ir.
Mashhad University of Medical Sciences · IRBam University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of this study was to investigate the acute toxic potential of cerium oxide nanoparticles (CNPs) synthesized by pullulan in adult male Wistar rats. PATIENTS AND

methodsThirty male Wistar rats randomly were divided into five experimental groups of six animals each. The animals were received 50, 100, 200, and 400 mg/kg CNPs for 14 consecutive days. At the end of the experiment, the rats were euthanized and histopathological evaluation of the liver and renal tissues, as well ass, the markers of serum oxidative stress including thiobarbituric acid reactive substances, total sulfhydryl content, and antioxidant capacity (using ferric reducing/antioxidant power assay) were assessed. Hematological parameters and the activity of liver function enzymes were also measured.

resultsThe results of this study showed that CNPs caused no significant changes in the activity of liver enzymes, hepatic and renal histopathology and hematological parameters, while significantly improved serum redox status.

conclusionAcute administration of pullulan-mediated CNPs is safe and possess antioxidant activity.

Indexed as

Toxicity TestsAnimalsAntioxidantsBiomarkersCatalaseCeriumIronKidneyLiverMaleMalondialdehydeNanoparticlesOxidation-ReductionOxidative StressRats, WistarSulfhydryl CompoundsAntioxidantsBiomarkersCatalaseceric oxideCeriumIronMalondialdehydeSulfhydryl CompoundsSuperoxide Dismutasegreen synthesismetal oxideradical scavengersol-geltoxicology

Identifiers

PMID31114200
PMCPMC6487897
OpenAlexW2942354323

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.